Opioids and Alternatives- Strategies to Optimize Success

Recorded February 8, 2023. This course is course is valid until February 3, 2026 and may be taken for credit up to that time.

Learning Objectives:

1.Describe how the role for the use of opioids in acute, chronic, cancer/palliative care and end-of-life pain has changed in the past decade.

2. Describe the key features of the 2022 Proposed CMS Recommendations/Guidelines for prescribing opioids for outpatients.

3.Differentiate addiction, physical dependency, and tolerance.

4.State key principles managing patients with ongoing therapy that includes opioid analgesics, including stating “red flags” for opioid misuse, abuse and diversion, and how to anticipate and manage adverse drug events.

5.Identify the main characteristics of patients who would be identified as "high risk", "moderate risk" and "low risk" for chronic opioid use.

6.State the definition of "hyperalgesia" and how to prevent/minimize this from negative- ly influencing the care of patients who are receiving opioids.

7.State three reasons why opioids may not be effective for some patients with chronic pain.

8.State key educational principles that should be applied to all patients and caregivers regarding the safe use, proper storage and disposal of opioids.

9.Compare and contrast the pharmacological benefits and risks of the following non-opioid pharmacological options for managing pain: a) cannabinoids; b) NSAIDS; c) anticonvulsants; and, d) antidepressants.

ACCREDITATION

University Learning Systems is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education.

California Board of Registered Nursing Provider No. CEP 11409, for 5 contact hours (0.5 CEU).

CE Broker Tracking #: 50-11357

PRINCIPAL AUDIENCE

PHARMACISTS: University Learning Systems reports credit to CPE Monitor.

This course provides 5 Home Study contact hours (0.5 CEU). UAN 0741-0000-22-024-H08-P ACTIVITY: KNOWLEDGE. No Partial credit is awarded.
This course is course is valid until December 9, 2025 and may be taken for credit up to that time.

CANADIAN PHARMACISTS: Canadian Council on Continuing Education in Pharmacy (CCCEP) accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE).

NURSE PRACTITIONERS/NURSES: This course provides 5 contact hours (0.5 CEU) of pharmacotherapeutics / pharmacology requirements for American Nurses Credentialing Center (ANCC) Category 1 Continuing Education Hours. The same hours submitted to renew certification may be submitted to a State Board of Nursing for re-licensure. American Nurses Credentialing Center (ANCC) accepts formally approved continuing education sponsored by organizations accredited or approved by the Accreditation Council for Pharmacy Education (ACPE).

OTHER HEALTH PROFESSIONALS: Please contact your respective board.

PHYSICIANS: This course may be considered for AMA Category 2 credit only.

CANADIAN PHYSICIANS: This course may be considered for AMA Category 2 credit only which may be equivalent to MAINPRO-M2 credits. Please contact your respective board.

PHYSICIAN ASSISTANTS: This course may be considered for AMA Category 2 credit only.

Gregory L. Holmquist, PharmD, CPE

Director and owner of Palliative Care Strategies, in Seattle, WA. He also provides direct patient care and consultative services for the chronic non-cancer pain and hospice teams at Group Health in Washington. Dr. Holmquist has made numerous presentations about pain management, symptom control and palliative care throughout the United States, and he has been involved in a number of clinical trials and other research studies. Dr. Holmquist received his undergraduate and graduate degrees from the School of Pharmacy at the University of Washington in Seattle. He is a board certified Oncology Pharmacist, an American Medical Association Certified Educator for Physicians on Endof-Life Care, and an American Society of Pain Educators Certified Pain Educator (C.P.E.). As a clinician and educator, Dr. Holmquist’s philosophy of care is summarized in one core statement, “Making a difference in the lives of patients”.

Previous
Previous

2023-02-09: Review of Women’s Health and Preventative Medicine

Next
Next

2023-01-20 : Comprehensive Update in Management of Diabetes Mellitus